RARE Ultragenyx
Company Analysis
Latest News
🟢 RARE is trading 4.1% up today amid a broader biotech and equity rebound
RARE is trading 4.1% up today at $29.94 as part of an ongoing rebound in biotech and broader equities after recent volatility. • There are no fresh...
🔴 RARE is trading 4.9% down today on profit-taking after recent biotech rally
RARE is trading 4.9% down at $27.35 as investors lock in gains following a sharp multi-day run-up in recent sessions. • The pullback appears to be a technical...
🟢 RARE extends move to 5.2% up
RARE is trading at $28.88, up 5.2% versus the comparison close of $27.44 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Ultragenyx is trading 4.1% up today, extending recent momentum
Ultragenyx is trading 4.1% up at $28.55 today, extending its strong gains over the past week on above-average intraday strength. • No fresh company-specific...
🟢 Ultragenyx is trading 4.2% up today amid new institutional investments and recent positive commentary from Goldman Sachs Healthcare Conference
• The stock is up 4.2% at $28.04 today, extending a multi-day rebound. • This follows recent participation in the Goldman Sachs 47th Annual Global Healthcare...
🟢 Ultragenyx makes sharp 10.2% jump
RARE is trading at $27.38, up 10.2% versus the comparison close of $24.85 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Ultragenyx is trading 8.1% up today as it rebounds from Q1 earnings and lawsuit-driven volatility
Ultragenyx is trading 8.1% up today at $26.85, rebounding after a volatile stretch tied to its Q1 2026 earnings miss and an ongoing securities class action...